Dawn Fallik

Freelance Writer / Journalism Professor / Investigative Medical Reporter

Dawn Fallik

is an award-winning reporter specializing in database analysis, medical coverage and digital storytelling. She is an associate professor at the University of Delaware who worked at The Wall Street Journal, The Philadelphia Inquirer and The Associated Press. She was co-director of the National Institute of Computer-Assisted Reporting.

She spent 15 years as a staff reporter for The Philadelphia Inquirer, The Associated Press and the St. Louis Post-Dispatch. She witnessed an execution, investigated medication errors and spent a month in India covering the tsunami rescue and recovery.

Learn More →

Home {Featured Content}

Associate Professor, University of Delaware

Dawn Fallik was director of UD’s journalism program for nine years between 2009 and 2022, at one point overseeing 250 students and coordinating with three other full-time faculty members. She created the journalism internship program in 2007, developing endowed fellowships with The News Journal and The Philadelphia Inquirer, before stepping down in 2022. Her students covered the Pope’s visit to Philadelphia, as well as White House credentials to cover speeches by Hillary Clinton, former President Bill Clinton, President Barack Obama and Michelle Obama. President Donald Trump denied the request for credentials.

She was a visiting professor at the University of Kansas from 2013-2015 She served on the Ochberg Society Board of Directors, teaching journalists how to cover traumatic situations.

Learn more →

Recent Stories

Fallik's work has appeared in The New Republic, The Wall Street Journal, The Philadelphia Inquirer, Philadelphia Magazine, Neurology Today, Poynter Institute and others.

Migraine Patients Often Don’t Receive Migraine Meds in ED

Neurology Today

Patients with migraine who presented to the emergency department (ED) typically did not receive migraine-specific medications, but instead were given anti-nausea medications and over-the-counter drugs like acetaminophen, according to an abstract presented during the American Headache Society (AHS) annual scientific meeting.